Related Experiment Video
Updated: May 26, 2026

02:21
Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
Nonischemic priapism following penile tattooing
Javaad Zargooshi1, Elham Rahmanian, Hiwa Motaee
1Rhazes Center for Research in Family Health and Sexual Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
The Journal of Sexual Medicine
|January 5, 2012
Summary
Penile tattooing can cause nonischemic priapism, a persistent erection. This case highlights tattooing as a potential cause, advising against the practice due to associated risks and treatment challenges.
Area of Science:
- Urology
- Dermatology
- Medical Case Reports
Background:
- Priapism is a prolonged erection, often painful, with numerous potential causes.
- Nonischemic priapism, specifically arterial priapism, involves excessive blood flow into the corpora cavernosa.
- The etiology of priapism is diverse, encompassing conditions like sickle cell disease, medications, and trauma.
Observation:
- A 21-year-old male presented with a 3-month history of partially rigid penis.
- Physical examination revealed penile tattoos and signs consistent with arterial priapism.
- The patient reported recent penile tattooing preceding the onset of priapism.
Findings:
- Standard priapism etiologies, including hematologic, infectious, and iatrogenic causes, were excluded.
- Penile blood gas analysis confirmed high oxygen and low carbon dioxide, indicative of arterial priapism.
- The patient underwent an unsuccessful Sacher procedure and opted against further treatment.
Implications:
- Penile tattooing should be recognized as a potential cause of nonischemic priapism.
- This case underscores the risks associated with penile tattooing and suggests it be discouraged.
- Further research into the mechanisms of tattooing-induced priapism may be warranted.
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

